Skip to main content
. 2022 Jan 6;23(1):3. doi: 10.1186/s10194-021-01377-6

Table 2.

Serum levels of NGF, BDNF, VEGF and PGE2 biomarkers in study groups

Biomarker Episodic migraine (n=23) Chronic migraine (n=36) Controls (n=30) P-value
Median (IQR) Median (IQR) Median (IQR)
NGF 63.11 (24.56) *, # 75.88 (31.89) * 90.58 (70.25) # 0.009
BDNF 0.49 (0.13) * 0.49 (0.14) # 1.05 (0.96) *, # <0.001
VEGF 937.41 (230.23) 932.56 (301.35) 646.50 (292.50) 0.046
PGE2 120.71 (19.47)* 134.16 (38.57) 153.50 (55.69)* 0.001

¶: Across group comparison (Kruskal-Wallis); *, #: significant adjusted P-value for pairwise-comparison (Dunn-Bonferroni); NGF: nerve growth factor; BDNF: brain-derived neurotrophic factor; VEGF: vascular endothelial growth factor; PGE2: prostaglandin E2